T1	Participants 503 574	Adult patients with measurable, locally advanced, and/or metastatic RCC
T2	Participants 391 480	treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC)
T3	Participants 1889 1973	treatment-naive and cytokine-pretreated patients with advanced and/or metastatic RCC
